Conference abstract
N-acetyl-serotonin and melatonin offer neuroprotection in experimental models of ischemic injury
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The identification of neuroprotective agents for stroke remains elusive. We therefore test whether melatonin receptor 1A agonists N-acetyl-serotonin (NAS) and melatonin are neuroprotective in experimental models of ischemic injury. We demonstrate that NAS and melatonin inhibits cell death induced by oxygen-glucose deprivation or H2O2 in primary cerebrocortical neurons and primary hippocampal neurons in vitro, and/or organotypic hippocampal slice cultures ex vivo. We further found that NAS and melatonin reduce hypoxia/ischemia injury in the middle cerebral artery occlusion mouse model of cerebral ischemia in vivo. Our data show that NAS and melatonin are neuroprotective by inhibiting the mitochondrial cell death pathway including the inhibition of the release of apoptogenic factors cytochrome c, Smac, and apoptosis-inducing factor from mitochondria to cytoplasm, and activation of caspase-3, -9. Furthermore, pro–IL-1 processing, and activation of caspase -1 are evaluated in melatonin-mediated neuroprotection. Moreover, we demonstrate that the neuroprotective effects of NAS may result from the influence of mitochondrial permeability transition pore opening, mitochondrial fragmentation, as well as the suppression of the autophagic cell death pathway under stress conditions by increasing LC3-II and Beclin-1 levels and decreasing p62 level. Taken together, we conclude that melatonin receptor 1A agonists NAS and melatonin have the potential as the novel therapies for ischemic injury.
Keywords
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBrain Disorders & Therapy
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Xin Wang”
